Direct Evidence That Polysorbate-80-Coated Poly (Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles
Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80–coated polybutylcyanoacrylate nanoparticles: An in situ brain perfusion study
Indirect Evidence that Drug Brain Targeting Using Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles Is Related to Toxicity
Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma
Hypotensive Action of Commercial Intravenous Amiodarone and Polysorbate 80 in Dogs.
Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells
Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain
Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol–polysorbate 80 mixture
Delayed effects of neonatal exposure to Tween 80 on female reproductive organs in rats.
Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: Structure and degradation pathways
Darbepoetin alfa (polysorbate 80)
Physicochemical properties of nanostructured lipid carriers as colloidal carrier system stabilized with polysorbate 20 and polysorbate 80